Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Clonidine Transdermal System
Brand Name
Clonidine Transdermal System Usp, 0.3 Mg/day
Generic Name
Clonidine Transdermal System
Active Ingredient
ClonidineCategory
Central alpha-2 Adrenergic Agonist [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| .3 mg/d | PATCH | TRANSDERMAL | 52817-612 |
Detailed information about Clonidine Transdermal System Usp, 0.3 Mg/day
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Clonidine Transdermal System Usp, 0.3 Mg/day, you must consult a qualified healthcare professional.
Clonidine is a centrally acting alpha-2 adrenergic agonist used primarily for hypertension and ADHD. It works by stimulating receptors in the brain to reduce sympathetic nervous system activity, thereby lowering blood pressure and improving focus.
Dosage for clonidine must be highly individualized and carefully titrated (adjusted) by a healthcare provider to achieve the desired therapeutic effect while minimizing side effects.
For most adults, the initial dose is 0.1 mg taken twice daily (morning and bedtime). If the blood pressure response is insufficient, your doctor may increase the dose by 0.1 mg per day at weekly intervals. Most patients find effective control within a range of 0.2 mg to 0.6 mg per day, divided into two doses. The maximum recommended dose is 2.4 mg per day, though such high doses are rarely used in modern practice.
The patch is typically started at the 0.1 mg/day strength. Because it takes 2 to 3 days for the drug to reach therapeutic levels from the patch, oral clonidine is often continued for the first few days of patch therapy. The patch is replaced every 7 days, and the application site should be rotated to prevent skin irritation.
Clonidine is primarily used in children for the treatment of ADHD. The FDA has approved the extended-release formulation (Kapvay) for patients aged 6 to 17 years.
Dosing usually begins at 0.1 mg at bedtime. The dose may be increased in increments of 0.1 mg per day at weekly intervals until the desired response is achieved. Doses are typically split, with the larger portion taken at bedtime to manage sedation. Total daily doses usually range from 0.1 mg to 0.4 mg. The immediate-release version is sometimes used off-label for ADHD or sleep, but this should only be done under strict pediatric supervision.
Because a significant portion of clonidine is excreted unchanged by the kidneys, patients with renal impairment (kidney disease) require careful monitoring. Lower starting doses and slower titration are often necessary. In patients on hemodialysis, clonidine is not significantly removed, so supplemental doses after dialysis are usually not required.
While the liver metabolizes about half of the dose, specific dosage adjustment guidelines for hepatic impairment are not well-established. However, clinicians should exercise caution in patients with severe liver disease due to the potential for altered drug metabolism.
Older adults are more sensitive to the sedative and hypotensive (blood pressure lowering) effects of clonidine. The 'Beers Criteria' for potentially inappropriate medication use in older adults suggests avoiding clonidine as a first-line treatment for hypertension due to the high risk of orthostatic hypotension (dizziness upon standing) and CNS effects. If used, dosing should start at the lowest possible level.
If you miss a dose of oral clonidine, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up. If you miss two or more doses, contact your healthcare provider immediately, as sudden cessation can lead to a dangerous spike in blood pressure.
Signs of a clonidine overdose include extreme drowsiness, constricted (pinpoint) pupils, slow heart rate (bradycardia), low blood pressure, and shallow breathing. In severe cases, a temporary spike in blood pressure may occur before the pressure drops dangerously low. If an overdose is suspected, call 911 or your local emergency services immediately. Emergency treatment often involves supportive care, intravenous fluids, and medications like atropine to increase the heart rate.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without direct medical guidance, as doing so can be life-threatening.
Clonidine is known for a specific profile of side effects related to its action on the central nervous system and the autonomic nervous system. The most frequently reported adverse effects include:
> Warning: Stop taking Clonidine and call your doctor immediately if you experience any of the following serious symptoms:
Prolonged use of clonidine may lead to certain chronic issues. Chronic dry mouth can lead to periodontal disease and tooth decay. Some patients may develop a tolerance to the antihypertensive effects, requiring dose adjustments. There is also a risk of developing 'clonidine withdrawal syndrome' if the medication is used for a long period and then stopped abruptly, which can involve tremors, agitation, and hypertensive crisis.
Currently, oral and transdermal clonidine do not carry an FDA Black Box Warning. However, the epidural formulation (Duraclon) carries a Black Box Warning regarding its use in obstetrical, postpartum, or perioperative pain management. It is not recommended for these uses because the risk of severe hemodynamic instability (low blood pressure and slow heart rate) outweighs the benefits in these specific populations. It should only be used in cancer patients where the benefits justify the risks.
Report any unusual symptoms or changes in your health to your healthcare provider promptly. Keeping a log of side effects can help your doctor determine if a dose adjustment is necessary.
Clonidine is a potent medication that requires careful management. The most critical safety point is the risk of rebound hypertension. You must never stop taking clonidine suddenly. Doing so can cause your blood pressure to skyrocket to dangerous levels within 8 to 24 hours, potentially leading to a stroke, heart attack, or encephalopathy (brain dysfunction). If you need to stop the medication, your doctor will provide a tapering schedule to slowly reduce the dose over several days or weeks.
As noted in the side effects section, the epidural form (Duraclon) is the only formulation with a Black Box Warning.
Duraclon Black Box Warning Summary:
There are no Black Box Warnings for the oral tablets or transdermal patches.
While taking clonidine, your healthcare provider will require regular monitoring to ensure the drug is safe and effective:
Clonidine frequently causes drowsiness and decreased mental alertness. You should not drive, operate heavy machinery, or engage in hazardous activities until you know how this medication affects you. The sedative effect is most pronounced during the first few days of treatment.
Alcohol should be avoided or strictly limited while taking clonidine. Alcohol significantly increases the sedative effects of clonidine, leading to dangerous levels of impairment, extreme drowsiness, and an increased risk of respiratory depression or falls.
If you and your doctor decide to stop clonidine, the dose must be reduced gradually. A typical taper involves reducing the dose every 2 to 4 days. If you are taking clonidine along with a beta-blocker (like metoprolol), the beta-blocker should be stopped several days before you begin tapering the clonidine to prevent a paradoxical rise in blood pressure.
> Important: Discuss all your medical conditions, especially heart or kidney problems, with your healthcare provider before starting Clonidine.
While there are few absolute contraindications for drug combinations with clonidine, certain pairings are highly discouraged due to the risk of severe adverse events:
Clonidine may interfere with certain diagnostic tests:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even 'natural' products can cause dangerous interactions with clonidine.
Clonidine must NEVER be used in the following circumstances:
These are conditions where the risk of using clonidine may outweigh the benefits, requiring a careful assessment by a physician:
There is a potential for cross-sensitivity between clonidine and other imidazoline-derivative drugs. If you have had a reaction to medications like lofexidine or dexmedetomidine, you must inform your healthcare provider before starting clonidine. Additionally, patients who develop a localized skin reaction to the clonidine transdermal patch may also develop a systemic rash if switched to oral clonidine tablets.
> Important: Your healthcare provider will evaluate your complete medical history, including any heart rhythm issues or allergies, before prescribing Clonidine.
Clonidine is classified as FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans. Clonidine readily crosses the placenta. While it is sometimes used for the management of hypertension in pregnancy when other agents have failed, it is not considered a first-line treatment. There is a risk that the drug could affect the heart rate and blood pressure of the developing fetus. Use during pregnancy should only occur if the potential benefit justifies the potential risk to the fetus. If you become pregnant while taking clonidine, do not stop the medication abruptly; contact your doctor immediately for a safe transition plan.
Clonidine is excreted in human breast milk. The concentration in breast milk can be nearly twice that of the mother's plasma. Because of the potential for serious adverse reactions in nursing infants—including slowed heart rate, low blood pressure, and sedation—a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. If breastfeeding continues, the infant must be closely monitored for excessive sleepiness and cardiovascular stability.
Clonidine is FDA-approved for the treatment of ADHD in children aged 6 to 17 years (specifically the extended-release Kapvay formulation). It has not been studied in children under age 6 for this purpose. When used in children, it is vital to monitor heart rate and blood pressure regularly. Clonidine is not approved for the treatment of hypertension in the pediatric population, although it is occasionally used off-label for this and other conditions like Tourette's. Parents should be aware that children may be more susceptible to the sedative effects of the drug.
Clinical studies of clonidine did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. However, general clinical experience suggests that elderly patients are at a much higher risk for side effects. The 'Beers Criteria' identifies clonidine as a potentially inappropriate medication for the elderly due to the risk of orthostatic hypotension, which can lead to falls and fractures, and CNS effects like confusion or sedation. In older adults with impaired kidney function, the drug stays in the system much longer, increasing the risk of toxicity.
In patients with renal (kidney) impairment, the half-life of clonidine is significantly prolonged. In patients with severe kidney disease, the half-life can reach 41 hours, compared to the normal 12-16 hours. Consequently, these patients require much lower doses and a slower titration schedule. Close monitoring of blood pressure is essential to prevent over-treatment and severe hypotension.
While the liver is responsible for metabolizing about half of the clonidine dose, there are no specific dosing adjustments provided in the manufacturer's labeling for patients with liver disease. However, clinicians should monitor these patients closely for signs of increased drug effect, as impaired liver function could theoretically lead to higher plasma concentrations.
> Important: Special populations, particularly the elderly and pregnant women, require individualized medical assessment and frequent monitoring when using Clonidine.
Clonidine is a centrally acting alpha-2 adrenergic agonist. Its primary site of action is the brainstem, specifically the vasomotor center in the medulla oblongata. By stimulating presynaptic alpha-2 receptors, clonidine activates an inhibitory G-protein (Gi) pathway. This leads to a decrease in the activity of adenylate cyclase and a subsequent reduction in cyclic AMP (cAMP) levels. The end result is a significant decrease in the release of norepinephrine from central sympathetic neurons. This reduction in 'sympathetic outflow' from the brain leads to a decrease in peripheral vascular resistance, heart rate, and blood pressure. Additionally, clonidine has an affinity for non-adrenergic imidazoline receptors, which may also play a role in its antihypertensive effects.
Following oral administration of the immediate-release form, the blood pressure begins to decline within 30 to 60 minutes. The maximum decrease in blood pressure occurs between 2 and 4 hours after the dose. The antihypertensive effect typically lasts for about 8 to 12 hours. In patients with ADHD, the pharmacodynamic effect is more complex and involves the strengthening of prefrontal cortical circuits. Unlike stimulants, which work immediately, the full behavioral effects of extended-release clonidine for ADHD may take 1 to 2 weeks to become apparent. Tolerance to the antihypertensive effects can occur in some patients with long-term use.
| Parameter | Value |
|---|---|
| Bioavailability | 75% - 95% |
| Protein Binding | 20% - 40% (primarily albumin) |
| Half-life | 12 - 16 hours (up to 41 hours in renal failure) |
| Tmax (Oral IR) | 1 - 3 hours |
| Metabolism | Hepatic (approx. 50%) via oxidation |
| Excretion | Renal 40% - 60% (unchanged), Fecal 20% |
Clonidine is classified as a Central Alpha-2 Adrenergic Agonist. It is related to other medications in this class such as guanfacine (Tenex, Intuniv) and methyldopa. While these drugs share a similar mechanism of reducing sympathetic tone, clonidine is unique in its wide range of delivery systems (patch, oral, epidural) and its specific affinity for both alpha-2 and imidazoline receptors.
Common questions about Clonidine Transdermal System Usp, 0.3 Mg/day
Clonidine is primarily used to treat high blood pressure (hypertension) and Attention Deficit Hyperactivity Disorder (ADHD). For hypertension, it works by relaxing blood vessels and slowing the heart rate through its action on the central nervous system. In the treatment of ADHD, specifically using the extended-release version, it helps improve focus and reduce impulsivity by modulating receptors in the brain's prefrontal cortex. Additionally, it is used in an epidural form for severe cancer pain management. Doctors also frequently prescribe it 'off-label' for conditions like opioid withdrawal symptoms, Tourette syndrome, and menopausal hot flashes.
The most common side effects reported by patients taking clonidine are dry mouth, drowsiness, dizziness, and constipation. Dry mouth occurs in nearly 40% of patients because the medication reduces the nerve signals that trigger saliva production. Drowsiness and sedation are also very common, especially when first starting the drug or increasing the dose. Many patients also experience lightheadedness when standing up quickly due to the drug's effect on blood pressure. These side effects often become less severe as your body adjusts to the medication over several weeks.
It is strongly recommended that you avoid or strictly limit alcohol consumption while taking clonidine. Both clonidine and alcohol act as central nervous system depressants, meaning they slow down brain activity. When taken together, they can cause extreme drowsiness, severe impairment of motor skills, and dangerous levels of sedation. This combination significantly increases the risk of falls, accidents, and respiratory depression. Always consult your healthcare provider before consuming alcohol if you are prescribed this medication.
Clonidine is considered a Pregnancy Category C medication, meaning its safety in human pregnancy has not been fully established. Animal studies have suggested potential risks to the fetus, and the drug is known to cross the placenta easily. While it is sometimes used for pregnancy-induced hypertension when other treatments are not suitable, it is not a first-line choice. If you are pregnant or planning to become pregnant, you must discuss the risks and benefits with your doctor. Never stop taking clonidine suddenly during pregnancy, as the resulting high blood pressure could be dangerous for both you and the baby.
The time it takes for clonidine to work depends on the condition being treated and the form of the medication. For high blood pressure, the immediate-release tablets begin to lower blood pressure within 30 to 60 minutes, reaching their peak effect in 2 to 4 hours. If you are using the transdermal patch, it can take 2 to 3 days for the medication to reach a steady therapeutic level in your bloodstream. For ADHD, while some calming effects may be noticed early on, it typically takes 1 to 2 weeks of consistent use for the full benefits on attention and hyperactivity to be realized.
No, you must never stop taking clonidine suddenly. Abruptly discontinuing this medication can lead to a dangerous condition called rebound hypertension, where your blood pressure rises rapidly to very high levels. This can cause severe headaches, tremors, anxiety, and in extreme cases, stroke or heart attack. If you need to stop the medication, your doctor will provide a specific schedule to gradually lower your dose over several days or weeks. This allows your nervous system to adjust slowly and prevents a life-threatening surge in catecholamines.
If you miss a dose of clonidine, take it as soon as you remember. However, if it is almost time for your next scheduled dose, you should skip the missed dose and continue with your regular dosing plan. Do not take two doses at once to make up for the missed one. If you miss more than two doses in a row, contact your healthcare provider immediately. Missing multiple doses increases the risk of experiencing withdrawal symptoms or a sudden spike in blood pressure, so professional medical guidance is necessary to get back on track safely.
Weight gain is not considered a common side effect of clonidine, but it can occur in some patients due to fluid retention (edema). Clonidine can cause the body to retain sodium and water, which may lead to swelling in the feet or ankles and a slight increase in scale weight. If you notice rapid weight gain (such as several pounds in a few days) or significant swelling, you should contact your doctor. This fluid retention can sometimes interfere with the drug's ability to lower blood pressure and may require the addition of a diuretic medication.
Clonidine can interact with many other medications, so it is vital to provide your doctor with a complete list of everything you take. It has significant interactions with beta-blockers, as stopping clonidine while on a beta-blocker can cause a severe blood pressure spike. It also interacts with other sedating drugs like opioids, benzodiazepines, and sleep medicines, which can lead to excessive drowsiness. Some antidepressants, specifically tricyclics, can reduce clonidine's effectiveness. Always check with a pharmacist or doctor before starting any new over-the-counter or prescription drugs while on clonidine.
Yes, clonidine is widely available as a generic medication in both immediate-release and extended-release tablet forms. The transdermal patch is also available as a generic (Clonidine Transdermal System). Generic versions are typically much more affordable than the original brand-name versions like Catapres or Kapvay and are required by the FDA to have the same active ingredient, strength, and effectiveness. Most insurance plans cover generic clonidine, making it an accessible option for long-term management of hypertension or ADHD.
Other drugs with the same active ingredient (Clonidine)